Patents by Inventor Meera RAMANUJAM

Meera RAMANUJAM has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • USE OF ANTI-CD40 ANTIBODIES FOR TREATMENT OF LUPUS NEPHRITIS
    Publication number: 20230265203
    Abstract: The present invention relates to new humanized antagonistic anti-CD40 antibodies and therapeutic and diagnostic methods and compositions for using the same for treating and/or preventing lupus nephritis.
    Type: Application
    Filed: October 7, 2022
    Publication date: August 24, 2023
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Scott Ronald BRODEUR, Thomas B. FREEMAN, Gerald Henry Nabozny, Meera RAMANUJAM, Paul SCHOLL, Juergen STEFFGEN
  • ANTI-IL-36R ANTIBODIES FOR THE TREATMENT OF A FIBROTIC CONDITION
    Publication number: 20230049147
    Abstract: The present invention provides methods for treating, preventing or ameliorating a fibrotic condition. The methods of the present invention include administering to a patient suffering from a fibrotic condition a therapeutically effective amount an anti-interleukin-36 receptor (anti-IL-36R) antibody.
    Type: Application
    Filed: August 12, 2022
    Publication date: February 16, 2023
    Inventors: Jay FINE, Marc Kaestle, Janine Lamar, David Lamb, Meera Ramanujam, Sudha Visvanathan
  • USE OF ANTI-CD40 ANTIBODIES FOR TREATMENT OF INFLAMMATORY CONDITIONS
    Publication number: 20220089759
    Abstract: The present invention relates to anti-CD40 antibodies and therapeutic methods for using the same for treating and/or preventing autoimmune or inflammatory diseases.
    Type: Application
    Filed: September 17, 2021
    Publication date: March 24, 2022
    Inventors: Fenglei HUANG, Meera RAMANUJAM, Juergen Theodor STEFFGEN, Yasuhiro TSUDA, Sudha VISVANATHAN
  • ANTI-IL-36R ANTIBODIES FOR THE TREATMENT OF NEUTROPHILIC DERMATOSES
    Publication number: 20220073628
    Abstract: The present invention provides methods for treating, preventing or ameliorating a neutrophilic dermatosis. The methods of the present invention include administering to a patient suffering from a neutrophilic dermatosis a pharmaceutical composition including an anti-interleukin-36 receptor (anit-IL-36R) antibody.
    Type: Application
    Filed: July 15, 2021
    Publication date: March 10, 2022
    Inventors: Jay FINE, Janine LAMAR, Steven John PADULA, Meera RAMANUJAM, Sudha VISVANATHAN
  • ANTI-IL-36R ANTIBODIES FOR THE TREATMENT OF ATOPIC DERMATITIS
    Publication number: 20220010022
    Abstract: The present invention provides methods for treating, preventing or ameliorating atopic dermatitis (AtD). In certain embodiments, the invention provides methods to reduce skin infection in a patient with atopic dermatitis. The methods of the present invention include administering to a patient in need thereof a pharmaceutical composition including an anti-interleukin-36 receptor (anit-IL-36R) antibody.
    Type: Application
    Filed: May 17, 2021
    Publication date: January 13, 2022
    Inventors: Mary Ruth FLACK, Jay FINE, Janine LAMAR, Steven John PADULA, Chandrasena Reddy PAMULAPATI, Meera RAMANUJAM, Ralf SIGMUND, Sudha VISVANATHAN, Elizabeta ZOVKO
  • USE OF ANTI-CD40 ANTIBODIES FOR TREATMENT OF LUPUS NEPHRITIS
    Publication number: 20190177420
    Abstract: The present invention relates to new humanized antagonistic anti-CD40 antibodies and therapeutic and diagnostic methods and compositions for using the same for treating and/or preventing lupus nephritis.
    Type: Application
    Filed: July 18, 2018
    Publication date: June 13, 2019
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Scott Ronald Brodeur, Thomas B. Freeman, Gerald Henery Nabozny, Meera Ramanujam, Paul Scholl, Juergen Steffgen
  • USE OF ANTI-CD40 ANTIBODIES FOR TREATMENT OF LUPUS NEPHRITIS
    Publication number: 20170058038
    Abstract: The present invention relates to new humanized antagonistic anti-CD40 antibodies and therapeutic and diagnostic methods and compositions for using the same for treating and/or preventing lupus nephritis.
    Type: Application
    Filed: August 31, 2016
    Publication date: March 2, 2017
    Inventors: Scott Ronald BRODEUR, Thomas B. FREEMAN, Gerald Henry NABOZNY, Meera RAMANUJAM, Paul SCHOLL, Juergen STEFFGEN